$SNDL

SNDL Inc.

1
3
0

No SEC Form 4 filings for $SNDL in the last 30 days.

See all $SNDL insider activity →

SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026

SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) will release its Q3 2026 financial results on October 27, 2026, before market open, followed by a conference call and webcast at 10:00 a.m. EDT. SNDL is a vertically integrated cannabis company and a major retail liquor and cannabis retailer in Canada.

SNDL sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning SNDL (SNDL Inc.). Coverage has skewed bullish: 1 bullish, 3 neutral, and 0 bearish.

Recent SNDL coverage spans earnings, corporate actions and financial news.

What's driving SNDL

AlphAI scores every news story that mentions SNDL with an AI model for sentiment and relevance, and aggregates insider trades from SNDL Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SNDL

Score
$SNDLMedAI 8/10

Alberta-based retailer hit by Canadians drinking less booze, smoking less weed

SNDL Inc, an Edmonton-based liquor and cannabis retailer, reported Q2 revenue down about 4% to $235.8 million and a nearly $8 million loss. Liquor sales fell about 5% to $134.7 million and cannabis store sales slipped 1.4% to $83.2 million. Management cited weaker Canadian demand and vape production issues, and said U.S. retail expansion in Florida, Texas and Massachusetts is pending.

$SNDLMedAI 8/10

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Net revenue fell 3.7% to C$235.8M and gross profit declined 16.6% to C$56.3M. Operating loss was C$(7.8)M. Cash flow was C$(30.2)M, with free cash flow C$(6.7)M. SNDL said it had C$183.2M unrestricted cash and no debt, and repurchased 11.7M shares. It also said a restructuring of Surterra’s Parallel is expected to give it control of medical cannabis operations in coming months.

$SNDLMedAI 8/10

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

SNDL Inc. (NASDAQ: SNDL) said it completed the April 29, 2026 acquisition of assets from Surterra Holdings and affiliates via a strict foreclosure. The deal reduces about US$842 million of Parallel debt and gives SNDL indirect majority economic exposure equivalent to 66.7% of TransactionCo equity and 69.4% of debt. Acquired assets include 56 retail and 3 cultivation/manufacturing sites with about US$150 million annualized revenue.

$CIAMedAI 8/10

Small caps to watch: Earnings from EQB, Coveo, Champion Iron and more

Canada’s S&P/TSX Small Cap Index is up about 67% over 52 weeks (record 1,472.68 on May 13), while the U.S. Russell 2000 is up about 40% (record 2,932.74 on Wednesday). EQB beat Q2 revenue/adjusted EPS but credit-loss provisions rose to $45.4M; revenue was $302–4M. Coveo’s Q4 matched expectations, but FY27 SaaS growth guidance (~9.5%) was seen below forecasts. Champion Iron Q4 revenue fell to $414.5M and net income to $23.2M. SNDL said its Ontario store purchase won’t proceed; it plans to realloc

$SNDLMed

SNDL Inc. Earnings Call: Cost Cuts Amid Cannabis Strain

SNDL Inc.'s recent earnings call highlighted revenue and margin pressures, especially in cannabis operations and liquor demand, but also emphasized strategic initiatives like the exclusive Jeter cannabis brand partnership, share buybacks, and cost savings. The company aims to restore momentum through a profit enhancement plan targeting over $20 million in operating income and increased international sales. Despite a top-line decline and negative free cash flow, SNDL foresees improved trends later in 2026, banking on these strategic shifts and regulatory tailwinds for its SunStream credit portfolio.

Related tickers